FarmaKeio Outsourcing LLC is recalling approximately 611,555 sterile testosterone and testosterone/triamcinolone acetonide pellets used for subcutaneous insertion. The recall was initiated due to manufacturing deviations that may result in the potential presence of metal particulate matter within the pellets. These prescription medications were distributed nationwide across the United States and to Antigua.
The presence of metal particles in a sterile pellet intended for insertion under the skin can cause local irritation, inflammation, or infection at the injection site. If metal matter enters the bloodstream or deeper tissues, it could pose more serious systemic health risks.
You have 2 options:
Recall #: D-0123-2026
Recall #: D-0124-2026
Recall #: D-0125-2026
Recall #: D-0126-2026
Recall #: D-0127-2026
Recall #: D-0128-2026
Recall #: D-0129-2026
Recall #: D-0130-2026
Recall #: D-0131-2026
Recall #: D-0132-2026
Recall #: D-0133-2026
Recall #: D-0134-2026
Recall #: D-0135-2026
Recall #: D-0136-2026
Recall #: D-0137-2026
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.